Esomeprazole and omeprazole could boost the serum concentrations of benzodiazepines (through CYP2C19 inhibition) leading to enhanced adverse effects for example drowsiness, although the scientific relevance is minimal for most patients – keep an eye on the client for adverse effects (e.If client are not able to resume their common oral medication